Siga Technologies Inc Receivables Turnover Ratio (SIGAQ), from the fourth quarter 2019 to the fourth quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Siga Technologies Inc  (SIGAQ)
 

Siga Technologies Inc Accounts Receivables Turnover Ratio from the fourth quarter 2019 to the fourth quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Siga Technologies Inc's ability to collect accounts receivable sequentially worsen to 149.34, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Average collection period, for Siga Technologies Inc's accounts receivable remained unchanged at 2 days, in the Dec 31 2019 quarter.

If we take a look into Healthcare sector 8 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2019 from 58 to 61.

What is Receivable Turnover Ratio?
What is Siga Technologies Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SIGAQ Receivables Turnover Ratio (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter
Y / Y Receivable Change 95.78 % 154.63 % - - -
Y / Y Revenue Change 60.23 % 364.05 % 105.52 % 37000.35 % 100.48 %
Receivable Turnover Ratio (TTM) 149.34 176.41 211.64 387.16 8.94
SIGAQ's Total Ranking # 61 # 58 # 59 # #
Accounts Receivable average collection period days 2 2 2 1 41
Seq. Receivable Change 29.53 % -22.06 % 168.15 % -27.69 % 68.47 %
Seq. Revenue Change -47.43 % 107.58 % -99.17 % 17601.51 % 52.25 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 5
Healthcare Sector # 9
Overall Market # 61

Receivable Turnover Ratio Statistics
High Average Low
387.16 158.88 8.94
(Sep 30 2018)   (Jun 30 2018)





SIGAQ Company Profile • Back to SIGAQ Efficiency Comparisons • Compare SIGAQ Receivables Turnover Ratio to its Competitors

Financial Statements
Siga Technologies Inc's Accounts Receivable $ 4 Millions Visit SIGAQ's Balance sheet
Siga Technologies Inc's Sales TTM $ 487 Millions Visit SIGAQ's Income Statement
Sources of SIGAQ's Revenues Visit SIGAQ's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SIGAQ's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SIGAQ's Growth Rates SIGAQ's Roa SIGAQ's Inventory Turnover Ratio SIGAQ's Dividend Comparisons
SIGAQ's Profitability Ratios SIGAQ's Roi SIGAQ's Asset Turnover Ratio SIGAQ's Dividend Growth
SIGAQ's Valuation Ratios SIGAQ's Roe SIGAQ's Financial Strength Ratios SIGAQ's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2019 Receivable at quarter ending Dec 31 2019
Waters Corporation  289.05 $ 2,406.596  Millions$ 8.326  Millions
Logicmark Inc  251.46 $ 17.137  Millions$ 0.068  Millions
Decoy Therapeutics Inc   236.69 $ 2.210  Millions$ 0.009  Millions
Bioadaptives Inc   220.76 $ 0.010  Millions$ 0.000  Millions
Optinose Inc   168.73 $ 34.631  Millions$ 0.205  Millions
Mersana Therapeutics inc   159.86 $ 42.123  Millions$ 0.264  Millions
Siga Technologies Inc  149.34 $ 487.358  Millions$ 3.263  Millions
Vystar Corporation  130.88 $ 13.686  Millions$ 0.105  Millions
Editas Medicine Inc   110.83 $ 20.531  Millions$ 0.185  Millions
Akcea Therapeutics Inc   102.88 $ 488.543  Millions$ 4.749  Millions
Voyager Therapeutics Inc   101.33 $ 104.391  Millions$ 1.030  Millions
H cyte Inc  95.40 $ 8.347  Millions$ 0.087  Millions
Icon Plc  90.11 $ 2,805.839  Millions$ 31.139  Millions
Hutchmed china Limited  85.48 $ 204.890  Millions$ 2.397  Millions
Fate Therapeutics Inc   85.44 $ 10.680  Millions$ 0.125  Millions
U s Stem Cell Inc   84.84 $ 3.072  Millions$ 0.036  Millions
Exicure Inc   76.24 $ 1.296  Millions$ 0.017  Millions
Affimed N v   72.27 $ 23.958  Millions$ 0.332  Millions
Lifemd Inc   71.33 $ 12.469  Millions$ 0.175  Millions
Blueprint Medicines Corporation  69.52 $ 66.512  Millions$ 0.957  Millions
Lifevantage Corp  60.39 $ 229.652  Millions$ 3.803  Millions
Galapagos Nv  59.97 $ 946.383  Millions$ 15.782  Millions
Wearable Health Solutions, Inc.  56.67 $ 1.694  Millions$ 0.030  Millions
Zealand Pharma A  54.93 $ 6.198  Millions$ 0.113  Millions
Scorpius Holdings inc   53.33 $ 3.049  Millions$ 0.057  Millions
Nanomix Corp  50.83 $ 0.016  Millions$ 0.000  Millions
U S Physical Therapy Inc  50.41 $ 481.969  Millions$ 9.562  Millions
Zeo Scientifix Inc   47.52 $ 2.223  Millions$ 0.047  Millions
Sonida Senior Living Inc   46.29 $ 447.100  Millions$ 9.659  Millions
Nature s Sunshine Products inc   45.57 $ 362.215  Millions$ 7.948  Millions

Date modified: 2026-09-08T15:22:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.